The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 17, 2013

Filed:

Mar. 13, 2008
Applicants:

Miao Dai, Shanghai, CN;

Feng He, Shanghai, CN;

Rishi Kumar Jain, Cambridge, MA (US);

Rajesh Karki, Cambridge, MA (US);

Joseph Kelleher, Iii, Cambridge, MA (US);

John Lei, Cambridge, MA (US);

Luis Llamas, Cambridge, MA (US);

Michael A. Mcewan, Cambridge, MA (US);

Karen Miller-moslin, Cambridge, MA (US);

Lawrence Bias Perez, Cambridge, MA (US);

Stefan Peukert, Cambridge, MA (US);

Naeem Yusuff, Cambridge, MA (US);

Inventors:

Miao Dai, Shanghai, CN;

Feng He, Shanghai, CN;

Rishi Kumar Jain, Cambridge, MA (US);

Rajesh Karki, Cambridge, MA (US);

Joseph Kelleher, III, Cambridge, MA (US);

John Lei, Cambridge, MA (US);

Luis Llamas, Cambridge, MA (US);

Michael A. Mcewan, Cambridge, MA (US);

Karen Miller-Moslin, Cambridge, MA (US);

Lawrence Bias Perez, Cambridge, MA (US);

Stefan Peukert, Cambridge, MA (US);

Naeem Yusuff, Cambridge, MA (US);

Assignee:

Novartis AG, Basel, CH;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07D 237/32 (2006.01); C07D 243/08 (2006.01); C07D 265/38 (2006.01); A61K 31/502 (2006.01); A61K 31/5377 (2006.01); A61K 31/5365 (2006.01); A61P 37/00 (2006.01); A61P 29/00 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present disclosure relates to compounds relating to the diagnosis and treatment of pathologies relating to the Hedgehog pathway, including but not limited to tumor formation, cancer, neoplasia, and non-malignant hyperproliferative disorders; specifically relating to compounds of formula I:


Find Patent Forward Citations

Loading…